Thermo Fisher Scientific, Cytonome enter partnership to co-develop flow cytometry platforms

June 21, 2016

Thermo Fisher Scientific and Cytonome will co-develop a new line of flow cytometry cell sorting technology.

Life sciences solutions company Thermo Fisher Scientific (Waltham, MA) has signed a strategic partnership agreement with cell sorting systems maker Cytonome (Boston, MA) to be the exclusive distributor of a new line of flow cytometry cell sorting technology that the companies will co-develop.

Systems that have very short learning curves and time-saving features are critical to expedite discovery, particularly for researchers who are not familiar with flow cytometry. Building on Cytonome's benchtop cell sorter platform, a key objective of the partnership is to develop easy-to-use technology designed to initiate a transformation where scientists can readily take advantage of cell sorting in their labs.

For more information, please visit www.thermofisher.com and www.cytonome.com.

About the Author

BioOptics World Editors

We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)